- Home
- BUUU vs INCR Comparison
BUUU vs INCR Comparison
Compare BUUU & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BUUU
- INCR
- Stock Information
- Founded
- BUUU 2017
- INCR 1994
- Country
- BUUU Hong Kong
- INCR Israel
- Employees
- BUUU N/A
- INCR N/A
- Industry
- BUUU Services-Misc. Amusement & Recreation
- INCR Biotechnology: Pharmaceutical Preparations
- Sector
- BUUU Consumer Discretionary
- INCR Health Care
- Exchange
- BUUU Nasdaq
- INCR Nasdaq
- Market Cap
- BUUU 68.1M
- INCR 78.0M
- IPO Year
- BUUU 2025
- INCR N/A
- Fundamental
- Price
- BUUU $8.30
- INCR $1.38
- Analyst Decision
- BUUU
- INCR
- Analyst Count
- BUUU 0
- INCR 0
- Target Price
- BUUU N/A
- INCR N/A
- AVG Volume (30 Days)
- BUUU 41.1K
- INCR 26.0K
- Earning Date
- BUUU 11-28-2025
- INCR 10-08-2025
- Dividend Yield
- BUUU N/A
- INCR N/A
- EPS Growth
- BUUU N/A
- INCR N/A
- EPS
- BUUU 0.05
- INCR N/A
- Revenue
- BUUU $6,328,425.00
- INCR $72,158,312.00
- Revenue This Year
- BUUU N/A
- INCR $69.54
- Revenue Next Year
- BUUU N/A
- INCR $41.75
- P/E Ratio
- BUUU $151.25
- INCR N/A
- Revenue Growth
- BUUU 8.88
- INCR N/A
- 52 Week Low
- BUUU $3.67
- INCR $1.17
- 52 Week High
- BUUU $9.50
- INCR $1.79
- Technical
- Relative Strength Index (RSI)
- BUUU N/A
- INCR 40.61
- Support Level
- BUUU N/A
- INCR $1.31
- Resistance Level
- BUUU N/A
- INCR $1.43
- Average True Range (ATR)
- BUUU 0.00
- INCR 0.06
- MACD
- BUUU 0.00
- INCR -0.00
- Stochastic Oscillator
- BUUU 0.00
- INCR 37.50
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.